Given that the books closed on Q3 Sept 30th, it seems the opportunity for significant billings is slim. Given their unwillingness/inability to provide guidance, it is hard to see anything other than a drubbing.
Unfortunately, IMO, even if the underlying numbers show traction and promise, I suspect the numbers as a whole hit with a thud no matter what.
Seeing that they book small order revs more-or-less straight away, there is an outside chance at a surprise in revs, but it would seem to me that no matter how solid those numbers look they will get drowned by the magnitude of the loss and cash on hand.
The above content is my opinion.
